A Safety and Tolerability Study of UBX0101 in Patients With Osteoarthritis of the Knee

NCT03513016 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

78

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis, Knee

Interventions

DRUG: UBX0101
OTHER: Placebo

Sponsor

Unity Biotechnology, Inc.